Retractable Technologies Inc. (NYSE American:RVP) traded today at a new 52-week high of $17.49. So far today approximately 1.8 million shares have been exchanged, as compared to an average 30-day volume of 1.8 million shares.
Over the past year, Retractable Technologies Inc. has traded in a range of $0.97 to $17.49 and is now at $16.28, 1,584% above that low.
Based on a current price of $16.28, Retractable Technologies Inc. is currently 86.5% above its average consensus analyst price target of $2.20.
Retractable Technologies Inc designs, develops, manufactures, and market patented safety medical products for the healthcare industry. It offers 1mL tuberculin; insulin syringes; allergy antigen VanishPoint syringes; 0.5mL, 2mL, 3mL, 5mL, and 10mL VanishPoint syringes; and the VanishPoint blood collection tube holder. The company also sells VanishPoint auto-disable syringes in the international market in addition to its other products. It distributes its products throughout the U.S. through the general line and specialty distributors. The maximum revenue derives from the US region as well as from Syringes products.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer